RESEARCH

Oncode Accelerator, Oncode Institute, and Cancer Research Horizons form strategic alliance during Dutch economic mission

International collaboration in cancer research has moved forward by the strategic alliance of Dutch sister organizations Oncode Accelerator and Oncode Institute with Cancer Research Horizons (the innovation arm of Cancer Research UK), which was signed during a Dutch economic mission to the UK.
Go to the profile of Saskia Theunisse
Saskia Theunisse
Marketing Manager, Oncode Accelerator
Oncode Accelerator, Oncode Institute, and Cancer Research Horizons form strategic alliance during Dutch economic mission
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

Share with...

This is a representation of how your post may appear on social media. The actual post will vary between social networks

During this week’s Dutch economic mission to the United Kingdom (led by the Netherlands Enterprise Agency (RVO), Dutch Ministry of Foreign Affairs, and the Dutch embassy in London), Oncode Institute, Oncode Accelerator and Cancer Research Horizons – the innovation arm of Cancer Research UK – took a significant step towards future collaboration with the signing of a joint Memorandum of Understanding (MoU).

Mark Krul, Chief Scientific Officer of Oncode Accelerator Foundation, commented on the significance of the MoU:  “The signing of this Memorandum of Understanding with our sister organization Oncode Institute and Cancer Research Horizons is an important moment for Oncode Accelerator as we expand our international collaboration efforts. This agreement strengthens our commitment to accelerating the development of new cancer therapies by working collaboratively with other experts in the field.”

Read the whole story here.

Oncode Accelerator is continuing to explore similar partnerships across Europe and beyond, and interested parties are welcome to reach out to [email protected]

Jan Paul Medema, Scientific Director and Head of Oncode Institute, Tony Hickson, Chief Business Officer of Cancer Research UK and Cancer Research Horizons, and Mark Krul, Chief Scientific Officer of Oncode Accelerator Foundation.

All images by pbmedia.

Go to the profile of Saskia Theunisse
Saskia Theunisse
Marketing Manager, Oncode Accelerator

Join the FEBS Network today

Joining the FEBS Network’s molecular life sciences community enables you to access special content on the site, present your profile, 'follow' contributors, 'comment' on and 'like' content, post your own content, and set up a tailored email digest for updates.

Sign In Register

Cookies

We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.

You can consent to the use of such technologies by closing this notice.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.